[RFA-HG-27-013] GREGoRi Innovation Projects (U01 Clinical Trial Optional)

Description

Titolo: GREGoRi Innovation Projects (U01 Clinical Trial Optional) Numero dell'opportunità: RFA-HG-27-013 Stato: aperto (posted) Tipo di opportunità: Discretionary Ente: National Institutes of Health — Department of Health and Human Services Tipo di finanziamento: Cooperative Agreement Categoria: Health Programma (ALN): 93.172 Human Genome Research Pubblicato il: 2026-06-18 Scadenza per le domande: 2026-10-30 Importo massimo per progetto: 500,000 USD Importo minimo per progetto: 3 USD Finanziamento totale stimato: 7,500,000 USD Numero di finanziamenti attesi: 10 Cofinanziamento richiesto: no Chi può fare domanda: Native American tribal governments (Federally recognized); Native American tribal organizations (other than Federally recognized tribal governments); State governments; Special district governments; City or township governments; Independent school districts; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Small businesses; County governments; Private institutions of higher education; Public and State controlled institutions of higher education; For profit organizations other than small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); Public housing authorities/Indian housing authorities; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Altre condizioni di eleggibilità: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. Descrizione: The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, that have the potential to make transformative improvements to the current state of the art. Contatto: [email protected]

Sectors

Source

Source: grants.gov